BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8231242)

  • 1. Restoration of impaired cytokine secretion from monocytes of patients with myelodysplastic syndromes after in vivo treatment with GM-CSF or IL-3.
    Maurer AB; Ganser A; Buhl R; Seipelt G; Ottmann OG; Mentzel U; Geissler RG; Hoelzer D
    Leukemia; 1993 Nov; 7(11):1728-33. PubMed ID: 8231242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of serum cytokine levels in patients with myelodysplastic syndromes.
    Verhoef GE; De Schouwer P; Ceuppens JL; Van Damme J; Goossens W; Boogaerts MA
    Leukemia; 1992 Dec; 6(12):1268-72. PubMed ID: 1280751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.
    Thomassen MJ; Ahmad M; Barna BP; Antal J; Wiedemann HP; Meeker DP; Klein J; Bauer L; Gibson V; Andresen S
    Cancer Res; 1991 Feb; 51(3):857-62. PubMed ID: 1988125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
    Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders.
    Ganser A; Janssen JW; Ottmann OG; Seipelt G; Eder M; Becher R; Lindermann A; Herrmann F; Schulz G; Mertelsmann R
    Leukemia; 1991 Jun; 5(6):487-92. PubMed ID: 1676079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective enhancement of GM-CSF, TNF-alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subjects.
    Hallsworth MP; Soh CP; Lane SJ; Arm JP; Lee TH
    Eur Respir J; 1994 Jun; 7(6):1096-102. PubMed ID: 7925879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.
    Zwierzina H; Suciu S; Loeffler-Ragg J; Neuwirtova R; Fenaux P; Beksac M; Harousseau J; Nuessler V; Cermak J; Solbu G; Willemze R; de Witte T; Amadori S;
    Leukemia; 2005 Nov; 19(11):1929-33. PubMed ID: 16151466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and granulocyte-monocyte colony stimulating factor secretion from human monocytes by an extract of Poria cocos.
    Tseng J; Chang JG
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):1-11. PubMed ID: 1306145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
    Baiocchi G; Scambia G; Benedetti P; Menichella G; Testa U; Pierelli L; Martucci R; Foddai ML; Bizzi B; Mancuso S
    Cancer Res; 1993 Mar; 53(6):1297-303. PubMed ID: 7680283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
    Kasper C; Zahner J; Sayer HG
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):497-502. PubMed ID: 12242514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha.
    Aloisi F; Carè A; Borsellino G; Gallo P; Rosa S; Bassani A; Cabibbo A; Testa U; Levi G; Peschle C
    J Immunol; 1992 Oct; 149(7):2358-66. PubMed ID: 1382099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-specific reduction in the expression of granulocyte--macrophage colony-stimulating factor receptor subunits in myelodysplastic syndromes.
    Shikama Y; Shichishima T; Ohto H; Jubinsky PT; Maruyama Y
    Br J Haematol; 2000 Dec; 111(3):863-72. PubMed ID: 11122148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
    Bergamaschi G; Cazzola M; Rosti V; Carlo-Stella C; Santini V; Ponchio L; Peverali FA; Della Valle G; Rossi Ferrini P; Ascari E
    Leukemia; 1991 Oct; 5(10):886-91. PubMed ID: 1961022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
    Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
    Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.